T1	Participants 319 330	70 patients
T2	Participants 352 367	treatment group
T3	Participants 376 391	control group u
T4	Participants 514 530	treatment group,
T5	Participants 580 594	control group.
T6	Participants 967 983	treatment group,
T7	Participants 1180 1190	two groups
T8	Participants 1247 1257	two groups
T9	Participants 1427 1442	treatment group
